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Abstract
Aim—To evaluate both the drug release profile and the effects on human dental pulp stem cells’ 
(hDPSC) proliferation and viability of novel bi-mix antibiotic-containing scaffolds intended for 
use as a drug-delivery system for root canal disinfection prior to regenerative endodontics.
Methodology—Polydioxanone (PDS)-based fibrous scaffolds containing both metronidazole 
(MET) and ciprofloxacin (CIP) at selected ratios were synthesized via electrospinning. Fibre 
diameter was evaluated based on scanning electron microscopy (SEM) images. Pure PDS 
scaffolds and a saturated CIP/MET solution (i.e. 50 mg of each antibiotic in 1 mL) (hereafter 
referred to as DAP) served as both negative (non-toxic) and positive (toxic) controls, respectively. 
High performance liquid chromatography (HPLC) was done to investigate the amount of drug(s) 
released from the scaffolds. WST-1® proliferation assay was used to evaluate the effect of the 
scaffolds on cell proliferation. LIVE/DEAD® assay was used to qualitatively assess cell viability. 
Data obtained from drug release and proliferation assays were statistically analysed at the 5% 
significance level.
Results—A burst release of CIP and MET was noted within the first 24 h, followed by a 
sustained maintenance of the drug(s) concentration for 14 days. A concentration-dependent trend 
was noticed upon hDPSCs’ exposure to all CIP-containing scaffolds, where increasing the CIP 
concentration resulted in reduced cell proliferation (P<0.05) and viability. In groups exposed to 
pure MET or pure PDS scaffolds, no changes in proliferation were observed.
Conclusions—Synthesized antibiotic-containing scaffolds had significantly lower effects on 
hDPSCs proliferation when compared to the saturated CIP/MET solution (DAP).
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Introduction
Treatment of pulpal necrosis of immature permanent teeth is challenging due to its uncertain 
prognosis (Andreasen et al. 2002, Ribeiro et al. 2008). Recently, regenerative endodontics 
has become a rational alternative to classical root apexification (Banchs & Trope 2004). It 
relies on copious chemical canal irrigation with minimal or no mechanical root canal 
preparation, followed by the application of a mixture of antibiotics for nearly one month 
(Banchs & Trope 2004, Geisler 2012). During the next visit, canal contents are removed via 
irrigation, and bleeding from periapical tissue is prompted (Murray et al. 2007). The evoked 
bleeding leads to the accumulation of undifferentiated stem cells (Lovelace et al. 2011), 
which, according to the literature, can play an important role in the regeneration of pulpal 
tissues (Murray et al. 2007, Diogenes et al. 2014). Overall, this innovative endodontic 
procedure has led, according to clinical cases and case series, to increased root length, apical 
closure, and continuing thickness of dentine walls, among other positive clinical findings 
(Banchs & Trope 2004, Kim et al. 2010, Petrino et al. 2010, Lin et al. 2013, Simon & Smith 
2014).
One of the most critical steps in regenerative endodontics is the complete eradication of 
residual infection (Albuquerque et al. 2014). Typically, this is achieved by the application of 
calcium hydroxide. As an alternative, triple antibiotic paste (TAP) containing CIP, MET, 
and minocycline or double antibiotic paste (DAP), containing CIP and MET, are used 
(Hoshino et al. 1996, Sato et al. 1996). Notably, the use of both calcium hydroxide and 
antibiotic pastes has demonstrated several important side-effects. The former has been 
associated with root weakening when used for both short (Sahebi et al. 2010, Yassen et al. 
2013) and long (Andreasen et al. 1989, Yassen et al. 2013, Moazami et al. 2014) periods of 
time. On the other hand, the use of clinically recommended dosages of TAP and DAP pastes 
has led to unfavourable effects on dental pulp cells (Ruparel et al. 2012, Chuensombat et al. 
2013), as well as periodontal ligament fibroblasts (Yadlapati et al. 2014), posing important 
questions toward the predictability of regenerative procedures. Moreover, current irrigation 
methods do not completely remove the remnants of antibiotic pastes from root canals 
(Berkhoff et al. 2014).
In light of this, drug delivery-based strategies, to reduce the local drug concentration through 
the use of antibiotic-containing nanofibres, have been proposed recently (Bottino et al. 2011, 
Bottino et al. 2013a, Bottino et al. 2014, Albuquerque et al. 2014, Palasuk et al. 2014, 
Waeiss et al. 2014). Therefore, the hypotheses of the study were that the amount of drug(s) 
released from these novel antibiotic-containing scaffolds (1) would lead to reduced cell 
toxicity, and more importantly (2) it would diminish the negative impact on hDPSC 
proliferation when compared to the double antibiotic (DAP) paste (i.e. ciprofloxacin and 
metronidazole mixture).
Materials and methods
Fabrication of the antibiotic-containing scaffolds
The synthesis of antibiotic-containing nanofibrous scaffolds has been described in detail 
(Bottino et al. 2011, Bottino et al. 2013a, Bottino et al. 2014, Palasuk et al. 2014, Waeiss et 
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al. 2014). Briefly, MET (Sigma-Aldrich, St. Louis, MO, USA) and CIP (Sigma-Aldrich) bi-
mix polydioxanone-based (PDS II®, Ethicon, Somerville, NJ, USA) solutions were prepared 
to obtain distinct MET/CIP-containing scaffolds. Pure MET and CIP scaffolds were also 
prepared. PDS pieces were dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP, Sigma-
Aldrich). MET and CIP were added alone and in different ratios (by weight, wt.%) into the 
PDS solutions and mixed overnight (Bottino et al. 2013a, Palasuk et al. 2014). The 
following groups of scaffolds were prepared: pure MET, pure CIP, 3:1MET/CIP, 1:1MET/
CIP, and 1:3MET/CIP (Palasuk et al. 2014). All antibiotic-containing PDS solutions were 
incorporated with 25 wt.% of antibiotic(s) in total relative to the PDS polymer weight (i.e., 
150 mg of drug(s) in total) (Bottino et al. 2013a). Pure PDS scaffolds and a saturated 
CIP/MET solution (i.e., 50 mg of each antibiotic in 1 mL) (DAP) (Sabrah et al. 2013) served 
as negative (non-toxic) and positive (toxic) controls, respectively. Antibiotic-containing 
solutions and pure PDS were loaded into 5 mL syringes (Becton-Dickinson, Franklin Lakes, 
NJ, USA) fitted with 27G metallic blunt-tip needles. Electrospinning was conducted at 2 
mL/h, from a distance of 18 cm and by applying electrical voltage between 15-18 kV. The 
scaffolds were processed at room temperature (RT) and then dried for at least 48 h (Bottino 
et al. 2013a). Scanning electron microscopy (SEM, JSM-5310LV, JEOL, Tokyo, Japan) was 
used to evaluate the morphological aspect of the synthesized scaffolds (Bottino et al. 2013a).
Drug Release
Four scaffolds (15 × 15 mm2) per group were initially weighed and incubated in 10 mL of 
phosphate buffered saline (PBS, pH 7.4, Fisher Scientific, Pittsburgh, PA, USA) and kept in 
an incubator at 37°C. Aliquots (1 mL) of each sample were collected at different time points 
(1, 2, 5, 7, and 14 days). Equal amounts of fresh PBS were added back to the incubation 
media subsequent to each aliquot retrieval (Bottino et al. 2013a). HPLC-UV analysis was 
performed on an Agilent 1100 system (Palo Alto, CA, USA), using a Zorbax SB-phenyl 
chromatography column (5 μm, 150 × 4.6 mm i.d) with a 10 μL injection volume. A binary 
mobile phase consisting of solvent systems A and B were used in gradient elution where A 
was 0.1% formic acid (v/v) in ddH2O and B was 0.1% formic acid (v/v) in acetonitrile. The 
mobile phase flow rate was 1.0 mL/min. Initial conditions were set at 95:5 A:B, followed by 
a linear gradient to 40:60 from 0 to 15 min. Gradient conditions were re-equilibrated to 95:5 
A:B from 15 to 16 min and held for 8 min at initial conditions until 23 min. Following 
separation, the column effluent was introduced into a UV-Vis photodiode array detector 
(Agilent). Quantitation wavelengths were 319 nm for MET and 278 nm for CIP. Retention 
times for MET and CIP were 5.4 min and 7.8 min, respectively. Standard curves for MET 
and CIP were generated using authentic standards, over a concentration range of 7 to 280 
μg/mL, and then the drug concentration in the aliquots was calculated. Drug release data are 
shown as the mean value plus or minus the standard deviation (±SD) of the mean. The 
percentage of the released drugs was then calculated based on the initial weight of the drug 
incorporated into the electrospun scaffolds (Bottino et al. 2013a).
Exposure of hDPSC to antibiotic-containing scaffolds
Low glucose Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Grand Island, NY, 
USA), supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT, USA) and 
1% penicillin– streptomycin (Sigma-Aldrich) in a humidified incubator at 37°C, with 5% 
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CO2, was used to culture hDPSC (catalogue number - DP003F, AllCells LLC, Alameda, 
CA, USA) obtained from permanent third molars. The medium was changed every 2-3 days 
and cells at passages 4-6 were used.
Electrospun samples (15 × 15 mm2, n=4/group) cut from the distinct antibiotic-containing 
scaffolds and the control (pure PDS) were mounted in a plastic device (CellCrownTM, 
Scaffdex, Tampere, Finland), disinfected in 70% ethanol for 30 min, and rinsed twice in 
sterile phosphate buffer saline (PBS, Sigma-Aldrich). Meanwhile, hDPSCs were harvested 
by trypsinization, counted, and seeded in 24-well plates at a density of 104/well (in 1500 μL 
of culture medium) on cell culture coverslips (Thermo Scientific Nunc, Rochester, NY, 
USA). After a 4 h incubation period to allow the cells to be attached, the plastic crowns with 
scaffolds were introduced into the wells. For standardization purposes, the crowns were 
separated from the bottom of the plate by a 2-mm distance achieved using plastic rings. 
Control (blank) columns were prepared with medium without cells and medium with cells 
but without any scaffolds (100% survival). In all the controls, for quality purposes, the 
crowns without scaffolds were introduced. As previously explained, a saturated solution of 
MET and CIP in complete culture media was used as an equivalent of the DAP (toxic 
control). The antibiotics were mixed at a concentration of 50 mg/mL of each antibiotic 
(Sabrah et al. 2013). Then, the solution was stirred for 4 h at RT, centrifuged at 3000 rpm 
for 15 min, and supernatant was filter-sterilized with a 0.22 μm syringe filter.
Evaluation of hDPSCs proliferation and viability
To assess the effects of antibiotic-containing scaffolds on hDPSC proliferation, the WST-1 
assay (Roche Diagnostics, Mannheim, Germany) was used according to the manufacturer's 
protocol. Briefly, after 3, 5, and 7 days, the CellCrowns™ were removed and 500 μL of 
culture media was left in the wells, following the addition of WST-1 reagent at the ratio of 
10:1. After 2 h of incubation in 5% CO2 in a humidified atmosphere at 37°C, the samples 
were transferred (100 μL) into 96-well plates. Full media with cells without exposure to 
scaffolds was assigned as the positive control and full media without cells was used as the 
negative control. The optical density (OD) of the incorporated dye was measured by reading 
the absorbance at 450 nm in a microplate reader against a blank column (Allam et al. 2011, 
Bottino et al. 2013b). Cell proliferation was calculated as a ratio of OD from experimental 
value to positive control, both subtracted by negative control (Allam et al. 2011, Bottino et 
al. 2013b).
LIVE/DEAD® assay (Molecular Probes, Invitrogen, Eugene, OR, USA) was used to assess 
the effects of antibiotic-containing scaffolds on hDPSC viability (Kim et al. 2013). Five 
samples for each experimental group were analysed at day 3 of exposure according to the 
manufacturer's instructions. To obtain a negative control, cells were treated with 70% 
methanol for 30 min and cells with no treatment were prepared as a positive control. In 
brief, LIVE/DEAD® assay uses calcein and ethidium homodimer (EthD-1). Calcein is 
converted into green product by intracellular esterase, which is active only in viable cells. 
By contrast, EthD-1, a red staining, has an affinity to nuclei. Nonetheless, in order to enter 
the nucleus, the cell membrane must be disrupted. As a result, EthD-1 is detected only in 
dead cells. Excitation and emission values for calcein and EthD-1 are 494/517 nm and 
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528/617 nm, respectively. Briefly, after warming LIVE/DEAD® reagent stock solutions to 
RT, 20 μL of 2 mM EthD-1 was mixed with 10 mL of sterile PBS to obtain a 4 μM EthD-1 
solution. Next, 5 μL of the component A (4 mM calcein stock solution) was added to the 10 
mL of 4 μM EthD-1 solution, yielding a 2 μM calcein AM solution. 100 μL of the LIVE/
DEAD® working solution was added to each well, followed by incubation at RT for 30 min. 
Immediately after all staining procedures (in the dark room), the cells were evaluated 
directly in the 24-well plates using an inverted fluorescence microscope (Leica DMI 4000B, 
Wetzlar, Germany) at 25× magnification with filters 480/527 and 546/600 for excitation/
emission, respectively. At least 6 pictures per group were acquired and analysed using 
Image-J software (NIH, Bethesda, MD, USA).
Statistical analysis
Drug release data were analysed by the Student's t-test. Data obtained from proliferation was 
analysed by one-way ANOVA. Tukey's post hoc test was used to compare differences 
among the groups at the same time point. The level of significance was set at α=0.05.
Results
Fibre morphology and drug release
Scanning electron microscopy (SEM) was used to examine the effect of drug(s) (MET, CIP, 
and MET/CIP mixtures) incorporation on the fibre morphology of the various antibiotic-
containing scaffolds synthesized via electrospinning. The results showed a submicron fibre 
diameter for all electrospun scaffolds. More importantly, fibres of the antibiotic-containing 
scaffolds had a visibly smaller mean fibre diameter than pure PDS (Fig. 1).
Drug release profiles from each group of antibiotic-containing scaffolds were examined 
using HPLC. The mean drug release, as well as the percentage (%) of drug release, was 
assessed up to 2 weeks as an initial screening of the potential ability of these scaffolds to 
function as drug delivery systems. A burst drug(s) release was noted within the first 24 h in 
all samples. The initial burst release was followed by an overall linear and sustained 
maintenance of the drug(s) concentration in the incubation media throughout the 14 days 
(Fig. 2). The mean MET drug released after 14 days for pure MET, 3:1 MET/CIP, 1:1 MET/
CIP, and 1:3 MET/CIP were 1870 ± 663.1 μg, 1260 ± 229 μg, 1068 ± 305.9 μg, and 536 ± 
71.6 μg, respectively (Fig. 2a). Meanwhile, the percentage (%) of MET drug released after 
14 days was 63% (3:1 MET/CIP), 69% (pure MET), and 93% for the 1:1 MET/CIP 
scaffolds (Fig. 2b). 1:1 MET/CIP scaffolds released all MET content by day 5 (Fig. 2b). The 
mean CIP drug released after 14 days for pure CIP, 3:1 MET/CIP, 1:1 MET/CIP, and 1:3 
MET/CIP were 966 ± 166.6 μg, 418 ± 96.8 μg, 674 ± 105 μg, and 900 ± 96.8 μg, 
respectively (Fig. 2c). After 14 days, the percentage (%) of CIP drug released ranged from 
32% for pure CIP to 63% for 3:1 MET/CIP scaffolds (Fig. 2d). No statistical differences in 
mean CIP release between pure CIP and 1:3 MET/CIP scaffolds (Fig. 2b) were observed. 
The percentage of CIP drug release was significantly lower (p<0.05) in pure CIP when 
compared to all other groups at all timepoints investigated (Fig. 2d).
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Human DPSCs proliferation and viability
The WST-1 proliferation assay was used to determine the indirect effects (i.e. drug(s) 
release) of antibiotic-containing scaffolds on hDPSCs proliferation. In brief, the 
colorimetric-based WST-1 assay makes use of a tetrazolium salt that generates a very water-
soluble formazan upon cellular reduction (Tominaga et al. 1999). The results of the assay 
revealed a significant (p<0.05) decrease in proliferation for all groups exposed to CIP-
containing scaffolds (Fig. 3) at all timepoints, in a concentration-dependent manner. In 
contrast, groups exposed to MET and pure PDS, showed no change in proliferation. In this 
study, Live/Dead assay was performed specifically to qualitatively evaluate cell morphology 
and viability after 3 days of scaffold exposure. Analysis of hDPSC viability by fluorescence 
microscopy revealed important differences among the groups. Cells exposed to either pure 
PDS or MET displayed a spindle-shaped fibroblastic cell body with mainly long cellular 
processes, with strong substrate attachment and associated multiple proliferating cells (Fig. 
4a-b). A visual decrease in cell number with a higher % of dead cells, indicated by the 
colour red, was observed after exposure to CIP-containing scaffolds. In addition, these cells 
showed a rounded form without cytoplasmic branched projections (Fig. 4c-f). No cells were 
seen after 3 days of exposure to the DAP-mimic solution (data not shown).
Discussion
Selection of the best method for eradication of root canal infection prior to regenerative 
endodontic procedures should be dictated by two major outcomes; that is, the maximization 
of the antibacterial efficiency while preserving the proliferation/differentiation potential of 
pulp stem cells (Trevino et al. 2011, Martin et al. 2014). Over the past few years, a myriad 
of studies has been performed (Bottino et al. 2013a, Bottino et al. 2014, Waeiss et al. 2014, 
Palasuk et al. 2014) focusing on the synthesis of antibiotic-containing scaffolds based on the 
central hypothesis that controlling the release rate of significantly lower (compared to the 
double and triple antibiotic pastes), yet effective antibiotic doses, might lead to enhanced 
human dental pulp stem cell viability (hDPSC), while preserving antimicrobial activity.
The drug release data indicated that, after an initial burst release (i.e. within the first 24 h), a 
continued maintenance of the drug(s) concentration for all timepoints was observed, 
suggesting a sustained level of drugs that might be effective in the eradication of existing 
infection. In fact, a recent study (Palasuk et al. 2014) revealed significant antimicrobial 
activity of these novel antibiotic-containing electrospun scaffolds over a 14-day period for 
different bacteria, comparable to activity provided by 0.12% chlorhexidine. Notably, the 
percentage of CIP was higher for 1:3 MET/CIP scaffolds when compared to those 
containing CIP only. This observation could be explained by pharmacokinetic interactions 
of both drugs. Solubility of MET is inversely proportional to pH, with the lowest solubility 
at about pH 8.0 (Rediguieri et al. 2011), whereas the solubility of CIP, a zwitterionic 
molecule, is optimal at neutral pH (Breda et al. 2009). Thus, MET presence in 1:3 MET/CIP 
could facilitate the release of CIP from the scaffolds due to physicochemical interactions. 
The important differences (i.e. a sizeable standard deviation) in mean fibre diameter among 
the antibiotic-containing groups might also play an important role in drug-release kinetics. 
Full optimization of the various electrospinning conditions, such as voltage and distance tip-
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collector, among others, will be explored in a future investigation to reduce the fibre 
diameter variability normally associated with electrospinning.
The long-term goal of this research is to translate into clinical practice a two-step tissue 
engineering-based strategy for regenerative endodontics by first establishing a bacteria-free 
environment conducive to tissue regeneration (Step 1) through the use of antibiotic-
containing scaffolds, followed by placement of a scaffold encapsulated with growth factors 
and/or stem cells (Step 2) to drive regeneration of the pulp-dentine complex (Albuquerque et 
al. 2014). Data from previous studies demonstrated convincing evidence of the antibacterial 
efficacy of PDS-based antibiotic-containing scaffolds (e.g., vancomycin, rifampicin, 
metronidazole, ciprofloxacin) against osteomyelitis-, periodontitis-, and root canal infection-
associated pathogens (Bottino et al. 2013a, Bottino et al. 2014, Waeiss et al. 2014, Palasuk 
et al. 2014). Here, novel antibiotic-containing scaffolds were evaluated in terms of their 
potential toxic effects to hDPSC using both proliferation and viability assays. Based on the 
data presented, the hypothesis was accepted, as the antibiotic-containing scaffolds promoted 
significantly lower cytotoxic effects when compared to the clinically advocated double 
antibiotic paste (DAP).
Calcium hydroxide [Ca(OH2)] is considered to be an excellent antimicrobial medication in 
endodontics, but its effectiveness can be limited to the main root canal with inadequate 
dentine penetration (Haapasalo & Ørstavik, 1987, Ercan et al. 2006), mostly due to low 
solubility and buffering dentine characteristics (Haapasalo et al. 2000, Portenier et al. 2001). 
Recently, antibiotic-containing pastes (i.e. TAP and DAP), at clinically advocated 
concentrations, have been shown to significantly affect the proliferation and survival of 
dental pulp cells (Chuensombat et al. 2013) as well as stem cells from the apical papilla 
(Ruparel et al. 2012). The present study confirms the highly toxic effects of DAP through 
the proliferation and viability assays after hDPSC exposure to the DAP-mimic, MET/CIP 
saturated solution.
From a clinical perspective, antimicrobials may act unfavourably on dental stem cells via 
two main mechanisms, i.e. diffusion to apical papilla during time of introduction into the 
root canal system, and/or by interference of residual drugs with migrating stem cells into the 
preformed blood clot. Of the two drug components in DAP, no change in either proliferation 
or viability of MET-only containing scaffolds was noticed. Even though there are studies 
indicating MET as being responsible for dose-dependent cytotoxic effects both in vitro 
(Kapoor et al. 1999) and in vivo (Chatzkel et al. 2010, Kuriyama et al. 2011), it has 
demonstrated favouring eukaryotic cell viability. MET has been shown to increase 
lymphocyte proliferation (Elizondo et al. 1994); however, the mechanism is not well 
understood. One plausible explanation is that MET can modulate proliferation through the 
release of inflammatory cytokines as observed in human periodontal ligament cells (Rizzo et 
al. 2010). Thus, MET, despite its proven antimicrobial characteristics, could also be 
considered to be a potential stem cell proliferation inducer when delivered locally using 
scaffolds to eliminate root canal infection. Regarding CIP, an inhibitory effect of all CIP-
containing polymer scaffolds on both proliferation and viability of hDPSCs was observed. 
Dose-dependent cytotoxic effects of antibiotics from the fluoroquinolones group, including 
CIP, were described elsewhere (Sobolewska et al. 2013). Lastly, an important decrease in 
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hDPSC viability for all samples exposed to CIP with a dose-dependent trend, where the least 
toxicity was seen in cells exposed to scaffolds with the lowest CIP content (3:1 MET/CIP). 
Future studies will focus on the determination of an optimal concentration of CIP with 
minimal or no toxic effects to stem cells, while still maintaining antimicrobial efficacy. In a 
clinical setting, the lowest possible CIP concentration within scaffolds with modulatory 
effects of MET, might lead to improvement in the survival, proliferation and regenerative 
capacity of dental pulp stem cells.
Conclusion
Synthesized antibiotic-containing scaffolds had significantly lower effects on hDPSCs’ 
proliferation and viability when compared to the saturated CIP/MET solution (DAP).
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Figure 1. 
(A-F) Representative SEM images of the electrospun antibiotic-containing scaffolds (5,000× 
magnification): (A) Pure PDS, (B) Pure MET, (C) 3:1MET/CIP, (D) 1:1MET/CIP, (E) 
1:3MET/CIP, and (F) Pure CIP.
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Figure 2. 
(A-D) Graphs represent both MET and CIP drug release for all antibiotic-containing 
scaffolds. (A) Mean MET drug release (in μg, ± SD, refer to inset Table). (B) Percentage of 
MET drug release (± SD, refer to inset Table) from the scaffolds based on initial weight. (C) 
Mean CIP drug release (in μg, ± SD, refer to inset Table). (D) Percentage of CIP drug 
release (± SD, refer to inset Table) from the scaffolds based on initial weight.
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Figure 3. 
Effects of pure PDS, antibiotic-containing scaffolds and DAP on hDPSCs proliferation. 
Proliferation was assessed via WST-1 assay after 3, 5, and 7 days of hDPSC exposure to the 
scaffolds and DAP solution. Data were plotted with mean (±SD). Statistical analyses were 
compared within the results from the same day. Correlation of upper case letter vs. lower 
case letter vs. lower case letter with apostrophe denotes statistical significance at the level of 
p<0.05.
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Figure 4. 
(A-F) Representative fluorescence microscopy images (25× magnification, scale bar = 100 
μm) show hDPSCs viability assessed with LIVE/DEAD® assay after exposure to scaffolds 
for 3 days: (A) Pure PDS; (B) MET; (C) 3:1MET/CIP; (D) 1:1MET/CIP; (E) 1:3MET/CIP; 
and (F) CIP. Cellular bodies stained green show viable cells. Arrows indicate red stained 
ethidium bromide positive nuclei (dead cells).
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